These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11914997)

  • 1. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.
    Vincent JL; Sun Q; Dubois MJ
    Clin Infect Dis; 2002 Apr; 34(8):1084-93. PubMed ID: 11914997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New therapeutic strategies in severe sepsis and septic shock].
    Oddo M; Schaller MD; Calandra T; Liaudet L
    Rev Med Suisse Romande; 2004 Jun; 124(6):329-32. PubMed ID: 15293439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel potential therapies for septic shock.
    Azevedo LC; Park M; Schettino GP
    Shock; 2008 Oct; 30 Suppl 1():60-6. PubMed ID: 18704007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 9. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial.
    Busund R; Koukline V; Utrobin U; Nedashkovsky E
    Intensive Care Med; 2002 Oct; 28(10):1434-9. PubMed ID: 12373468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis: clinical dilemmas.
    Murray MJ
    Yale J Biol Med; 1998; 71(6):485-91. PubMed ID: 10604781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe sepsis and septic shock in the emergency department.
    Talan DA; Moran GJ; Abrahamian FM
    Infect Dis Clin North Am; 2008 Mar; 22(1):1-31, v. PubMed ID: 18295681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sepsis criteria, and selection of patients for immunotherapy.
    Thijs LG
    Prog Clin Biol Res; 1994; 388():407-15. PubMed ID: 7831372
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock.
    Pontes-Arruda A; Aragão AM; Albuquerque JD
    Crit Care Med; 2006 Sep; 34(9):2325-33. PubMed ID: 16850002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of a quality improvement bundle in bridging the gap between research and standard care in the management of severe sepsis and septic shock in the emergency department.
    Nguyen HB; Lynch EL; Mou JA; Lyon K; Wittlake WA; Corbett SW
    Acad Emerg Med; 2007 Nov; 14(11):1079-86. PubMed ID: 17923718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmapheresis in the treatment of septic shock].
    Busund R
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):776-8. PubMed ID: 15039806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials].
    Montravers P; Lasocki S; Seguin P; Malledant Y
    Ann Fr Anesth Reanim; 2007 Apr; 26(4):363-9. PubMed ID: 17336486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of severe sepsis and septic shock.
    Morrell MR; Micek ST; Kollef MH
    Infect Dis Clin North Am; 2009 Sep; 23(3):485-501. PubMed ID: 19665079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.